Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT05275868 · TERMINATED
Trial details
- NCT number
- NCT05275868
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2025-10-13
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.